Medicare Part D coverage · enalapril maleate · RxCUI 858828
enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet
Per the CMS 2026 Part D formulary file, enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet is covered by 4,366 Medicare Part D plans (86.4% of enrollable products), averaging Tier 2.2, with prior authorization required on 0% of covering formularies.
- 86.4%
- Plan coverage
- 4,366
- Plans covering
- T2.2
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet
Per the CMS 2026 Part D formulary file, enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet (RxNorm concept RXCUI 858828, generic name enalapril maleate) appears on 309 distinct formulary files spanning 4,366 Medicare Part D plan offerings - 86.4% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.2.
Real-world access to enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 14.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 482,684 Part D beneficiaries filled enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $53,664,853 and an average per-beneficiary annual cost of $111.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 309
- Plans covering
- 4,366
- Coverage rate
- 86.4%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 14.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 482,684
- Total spending
- $53,664,853
- Avg per beneficiary
- $111.18
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T1 | No | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T1 | No | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T1 | No | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 98 plans.
Frequently Asked Questions
Is enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet covered by Medicare Part D?
Yes, enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet is covered by 4,366 Medicare Part D plans (86.4% of all Part D formularies).
What tier is enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet on Medicare Part D plans?
enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet averages Tier 2.2 across Part D plans, ranging from Tier 1 to Tier 6.
Does enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet. Step therapy: 0%. Quantity limits: 14.9%.
How much does Medicare spend on enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet?
In 2023, total Medicare Part D spending on enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet was $53,664,853, covering 482,684 beneficiaries. The average spend per beneficiary was $111.18.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] T2.2
- 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert] T2.2
- {10 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 150 MG /100 MG Dose Pack] T2.2
- {20 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 5-Day] T2.2
- imiquimod 50 MG/ML Topical Cream T2.2
- Salmonella typhi Ty21a live antigen 2000000000 UNT Delayed Release Oral Capsule [Vivotif] T2.2
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA